Share Price and Basic Stock Data
Last Updated: November 7, 2025, 7:22 pm
| PEG Ratio | 31.08 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Fundviser Capital (India) Ltd operates in the Finance & Investments sector, with a current market capitalization of ₹121 Cr. The company’s share price stood at ₹205, reflecting investor sentiment amidst varying revenue performance. Over the last few quarters, the sales figures have shown significant fluctuations. For instance, in the September 2023 quarter, sales rose sharply to ₹0.62 Cr, recovering from a negative ₹0.03 Cr in the March 2023 quarter. However, the revenue for the preceding quarters, such as the June 2022 and September 2022 quarters, remained stagnant at ₹0.02 Cr, indicating inconsistent operational effectiveness. Annually, the total sales have increased to ₹2.17 Cr in FY 2025 from ₹0.22 Cr in FY 2023, showcasing a notable growth trajectory despite past challenges. The trailing twelve months (TTM) revenue is recorded at ₹1.25 Cr, reflecting the company’s potential for recovery and growth in a challenging market environment.
Profitability and Efficiency Metrics
Fundviser Capital has faced significant profitability challenges as evidenced by its operating profit margins (OPM), which stood at -100.00% in the latest reporting period. The reported net profit for FY 2025 was ₹0.43 Cr, a slight improvement from a net loss of ₹0.01 Cr in FY 2023. The company’s return on equity (ROE) is relatively low at 2.88%, and the return on capital employed (ROCE) is at 3.76%, both indicating underperformance compared to industry benchmarks. The interest coverage ratio was notably strong at 24.74x, suggesting that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) has increased to 79.06 days, reflecting inefficiencies in managing receivables and payables. This inefficiency may hinder the company’s ability to generate cash flow and invest in growth opportunities. Overall, while some signs of profitability are emerging, the company still grapples with substantial operational challenges.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fundviser Capital is characterized by a conservative financial structure, with no reported borrowings of ₹0.00 Cr. This positions the company favorably in terms of financial risk management. The total assets rose to ₹16.81 Cr in FY 2025, up from ₹6.54 Cr in FY 2023, largely attributed to an increase in reserves, which reached ₹11.43 Cr. The price-to-book value (P/BV) ratio stood at 4.04x, indicating that the stock is trading at a premium compared to its book value of ₹36.33 per share. The current ratio of 1.33x and quick ratio of 1.33x suggest adequate liquidity to cover short-term liabilities. However, the net profit margin of 8.00% and operating profit margin of 26.27% point to ongoing profitability concerns. The company’s ability to convert its assets into revenue effectively remains a critical area for improvement, as indicated by the high operating expenses relative to sales.
Shareholding Pattern and Investor Confidence
Fundviser Capital’s shareholding pattern indicates a strong promoter presence, with promoters holding 66.36% of the equity as of June 2025, up from 53.12% in the previous quarters. This increasing stake may signal confidence among promoters regarding the company’s future prospects. However, foreign institutional investors (FIIs) have not invested in the company, while domestic institutional investors (DIIs) hold a mere 0.42%. The public shareholding has decreased to 33.22%, suggesting a potential lack of confidence or interest from retail investors. The number of shareholders has also declined to 3,710 in June 2025 from 4,070 in September 2022, indicating a shrinking investor base. This dynamic could be a concern for the company’s liquidity and market perception. The concentrated promoter holding, while indicating commitment, may also raise red flags regarding governance and transparency.
Outlook, Risks, and Final Insight
Looking ahead, Fundviser Capital faces a mixed outlook. The company’s ability to sustain revenue growth and improve profitability will be pivotal. The strong interest coverage ratio and absence of debt provide a solid foundation for navigating financial challenges. However, risks remain, including fluctuating sales, low margins, and operational inefficiencies. The increasing cash conversion cycle may pose liquidity risks if not addressed. Furthermore, investor confidence could be impacted by the declining public shareholding and lack of institutional interest. Should the company capitalize on its growing reserves and improve operational efficiency, it could attract more investors and enhance its market position. Conversely, failure to address these challenges may lead to continued volatility in its financial performance and investor sentiment.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Fundviser Capital (India) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.6 Cr. | 43.0 | 67.7/36.4 | 50.4 | 44.4 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,419 Cr. | 305 | 484/280 | 15.7 | 102 | 0.33 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.14 Cr. | 8.36 | 12.6/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 30.3 Cr. | 58.9 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,983.10 Cr | 1,374.58 | 108.16 | 3,835.00 | 0.32% | 21.70% | 14.20% | 7.28 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.02 | 0.03 | -0.03 | 0.02 | 0.62 | 0.08 | 0.25 | 0.01 | 0.00 | 0.32 | 0.61 | 0.32 |
| Expenses | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.20 | 0.04 | 0.09 | 0.70 | 0.77 | 0.64 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.09 | -0.38 | -0.16 | -0.32 |
| OPM % | -150.00% | -150.00% | -100.00% | -200.00% | 91.94% | 12.50% | 20.00% | -300.00% | -118.75% | -26.23% | -100.00% | ||
| Other Income | 0.01 | 0.02 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 1.10 | 0.12 | 0.20 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Profit before tax | -0.02 | -0.01 | 0.12 | -0.10 | -0.04 | 0.57 | 0.01 | 0.05 | -0.03 | -0.08 | 0.72 | -0.04 | -0.13 |
| Tax % | 0.00% | 0.00% | 16.67% | -10.00% | -25.00% | 12.28% | 400.00% | 80.00% | -33.33% | -25.00% | 25.00% | -50.00% | 0.00% |
| Net Profit | -0.01 | -0.01 | 0.10 | -0.09 | -0.03 | 0.50 | -0.03 | 0.00 | -0.02 | -0.06 | 0.54 | -0.02 | -0.12 |
| EPS in Rs | -0.03 | -0.03 | 0.27 | -0.24 | -0.08 | 1.36 | -0.08 | 0.00 | -0.04 | -0.13 | 1.05 | -0.04 | -0.20 |
Last Updated: August 19, 2025, 3:10 pm
Below is a detailed analysis of the quarterly data for Fundviser Capital (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.61 Cr. (Mar 2025) to 0.32 Cr., marking a decrease of 0.29 Cr..
- For Expenses, as of Jun 2025, the value is 0.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.77 Cr. (Mar 2025) to 0.64 Cr., marking a decrease of 0.13 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from -0.16 Cr. (Mar 2025) to -0.32 Cr., marking a decrease of 0.16 Cr..
- For OPM %, as of Jun 2025, the value is -100.00%. The value appears to be declining and may need further review. It has decreased from -26.23% (Mar 2025) to -100.00%, marking a decrease of 73.77%.
- For Other Income, as of Jun 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.12 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 0.08 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.13 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Mar 2025) to -0.13 Cr., marking a decrease of 0.09 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -50.00% (Mar 2025) to 0.00%, marking an increase of 50.00%.
- For Net Profit, as of Jun 2025, the value is -0.12 Cr.. The value appears to be declining and may need further review. It has decreased from -0.02 Cr. (Mar 2025) to -0.12 Cr., marking a decrease of 0.10 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.20. The value appears to be declining and may need further review. It has decreased from -0.04 (Mar 2025) to -0.20, marking a decrease of 0.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:19 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.21 | 3.61 | 0.00 | 0.00 | 0.34 | 0.25 | 0.28 | 0.24 | 0.15 | 0.22 | 0.97 | 2.17 | 1.25 |
| Expenses | 3.82 | 3.78 | 1.85 | 0.39 | 0.34 | 0.29 | 0.23 | 0.20 | 0.21 | 0.23 | 0.37 | 1.60 | 2.20 |
| Operating Profit | -0.61 | -0.17 | -1.85 | -0.39 | 0.00 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 | -0.95 |
| OPM % | -19.00% | -4.71% | 0.00% | -16.00% | 17.86% | 16.67% | -40.00% | -4.55% | 61.86% | 26.27% | -76.00% | ||
| Other Income | 0.17 | 0.23 | 3.27 | 0.49 | 0.00 | 0.13 | 0.01 | 0.60 | 0.05 | 0.00 | 0.00 | 0.00 | 1.43 |
| Interest | 0.02 | 0.03 | 0.00 | 0.06 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.30 | 0.68 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Profit before tax | -0.76 | -0.65 | 1.41 | 0.04 | -0.02 | 0.07 | 0.06 | 0.64 | -0.01 | -0.01 | 0.59 | 0.56 | 0.47 |
| Tax % | -5.26% | -24.62% | -8.51% | 25.00% | 50.00% | 0.00% | 66.67% | 17.19% | 200.00% | 0.00% | 25.42% | 23.21% | |
| Net Profit | -0.73 | -0.48 | 1.53 | 0.02 | -0.03 | 0.07 | 0.02 | 0.52 | -0.03 | -0.01 | 0.44 | 0.43 | 0.34 |
| EPS in Rs | -1.98 | -1.30 | 4.15 | 0.05 | -0.08 | 0.19 | 0.05 | 1.41 | -0.08 | -0.03 | 1.19 | 0.83 | 0.68 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 34.25% | 418.75% | -98.69% | -250.00% | 333.33% | -71.43% | 2500.00% | -105.77% | 66.67% | 4500.00% | -2.27% |
| Change in YoY Net Profit Growth (%) | 0.00% | 384.50% | -517.44% | -151.31% | 583.33% | -404.76% | 2571.43% | -2605.77% | 172.44% | 4433.33% | -4502.27% |
Fundviser Capital (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 47% |
| 3 Years: | 135% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 85% |
| 3 Years: | 154% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 100% |
| 3 Years: | 142% |
| 1 Year: | 49% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: July 25, 2025, 1:16 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 3.69 | 4.47 | 5.15 |
| Reserves | 0.73 | 0.25 | 1.78 | 2.04 | 2.00 | 2.08 | 2.10 | 2.62 | 2.52 | 2.79 | 8.76 | 11.43 |
| Borrowings | 0.42 | 0.13 | 0.40 | 0.19 | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.55 | 0.20 | 0.14 | 0.05 | 0.06 | 0.03 | 0.20 | 0.13 | 0.02 | 0.06 | 0.09 | 0.23 |
| Total Liabilities | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 |
| Fixed Assets | 2.22 | 1.54 | 0.09 | 0.08 | 0.08 | 1.17 | 1.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.03 | 0.02 | 0.52 | 0.69 | 0.65 | 0.17 | 0.17 | 0.17 | 3.09 | 3.20 | 2.61 | 11.53 |
| Other Assets | 3.14 | 2.71 | 5.40 | 5.20 | 5.38 | 4.46 | 4.53 | 6.27 | 3.14 | 3.34 | 10.71 | 5.23 |
| Total Assets | 5.39 | 4.27 | 6.01 | 5.97 | 6.11 | 5.80 | 5.99 | 6.44 | 6.23 | 6.54 | 13.32 | 16.81 |
Below is a detailed analysis of the balance sheet data for Fundviser Capital (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.15 Cr.. The value appears strong and on an upward trend. It has increased from 4.47 Cr. (Mar 2024) to 5.15 Cr., marking an increase of 0.68 Cr..
- For Reserves, as of Mar 2025, the value is 11.43 Cr.. The value appears strong and on an upward trend. It has increased from 8.76 Cr. (Mar 2024) to 11.43 Cr., marking an increase of 2.67 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Mar 2024) to 0.23 Cr., marking an increase of 0.14 Cr..
- For Total Liabilities, as of Mar 2025, the value is 16.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.32 Cr. (Mar 2024) to 16.81 Cr., marking an increase of 3.49 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.05 Cr., marking an increase of 0.05 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 11.53 Cr.. The value appears strong and on an upward trend. It has increased from 2.61 Cr. (Mar 2024) to 11.53 Cr., marking an increase of 8.92 Cr..
- For Other Assets, as of Mar 2025, the value is 5.23 Cr.. The value appears to be declining and may need further review. It has decreased from 10.71 Cr. (Mar 2024) to 5.23 Cr., marking a decrease of 5.48 Cr..
- For Total Assets, as of Mar 2025, the value is 16.81 Cr.. The value appears strong and on an upward trend. It has increased from 13.32 Cr. (Mar 2024) to 16.81 Cr., marking an increase of 3.49 Cr..
Notably, the Reserves (11.43 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.03 | -0.30 | -2.25 | -0.58 | -0.36 | -0.04 | 0.05 | 0.04 | -0.06 | -0.01 | 0.60 | 0.57 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 36.39 | 30.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Inventory Days | 65.51 | 11.36 | ||||||||||
| Days Payable | 10.92 | 0.00 | ||||||||||
| Cash Conversion Cycle | 90.98 | 41.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 63.97 | 79.06 | ||
| Working Capital Days | 185.34 | 121.33 | -21.47 | 160.60 | 26.07 | 2,843.96 | 97.33 | 49.77 | 989.64 | 518.06 | ||
| ROCE % | -13.70% | -14.81% | -2.01% | 1.70% | 0.67% | -0.17% | 1.04% | 0.99% | -0.16% | -1.42% | 6.09% | 3.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.17 |
| Diluted EPS (Rs.) | 4.50 |
| Cash EPS (Rs.) | 5.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 36.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 36.33 |
| Revenue From Operations / Share (Rs.) | 64.60 |
| PBDIT / Share (Rs.) | 5.79 |
| PBIT / Share (Rs.) | 5.75 |
| PBT / Share (Rs.) | 5.51 |
| Net Profit / Share (Rs.) | 5.17 |
| NP After MI And SOA / Share (Rs.) | 3.07 |
| PBDIT Margin (%) | 8.97 |
| PBIT Margin (%) | 8.89 |
| PBT Margin (%) | 8.53 |
| Net Profit Margin (%) | 8.00 |
| NP After MI And SOA Margin (%) | 4.75 |
| Return on Networth / Equity (%) | 8.45 |
| Return on Capital Employeed (%) | 11.64 |
| Return On Assets (%) | 2.90 |
| Total Debt / Equity (X) | 0.39 |
| Current Ratio (X) | 1.33 |
| Quick Ratio (X) | 1.33 |
| Interest Coverage Ratio (X) | 24.74 |
| Interest Coverage Ratio (Post Tax) (X) | 23.08 |
| Enterprise Value (Cr.) | 87.19 |
| EV / Net Operating Revenue (X) | 2.62 |
| EV / EBITDA (X) | 29.20 |
| MarketCap / Net Operating Revenue (X) | 2.27 |
| Price / BV (X) | 4.04 |
| Price / Net Operating Revenue (X) | 2.27 |
| EarningsYield | 0.02 |
After reviewing the key financial ratios for Fundviser Capital (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 25, the value is 4.50. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.22. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.33. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 64.60. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.79. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.75. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 25, the value is 5.51. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.07. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 25, the value is 8.97. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 25, the value is 8.89. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 25, the value is 8.53. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 25, the value is 8.00. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.75. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.45. This value is below the healthy minimum of 15. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 25, the value is 11.64. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.39. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 25, the value is 1.33. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 25, the value is 1.33. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.74. This value is within the healthy range. No previous period data is available for comparison.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.08. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 25, the value is 87.19. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 25, the value is 29.20. This value exceeds the healthy maximum of 15. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 25, the value is 4.04. This value exceeds the healthy maximum of 3. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fundviser Capital (India) Ltd:
- Net Profit Margin: 8%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.64% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.45% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 23.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 372 (Industry average Stock P/E: 108.16)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.39
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | 22, 7th Floor, Manek Mahal, Next to Ambassador Hotel, Mumbai Maharashtra 400020 | info@fundvisercapital.in http://www.fundvisercapital.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prem Krishan Jain | Chairman & Managing Director |
| Mrs. Kriti Jain | Whole Time Director |
| Mr. Triloki Nath Bansal | Independent Director |
| Mr. Vinodkumar Singh | Independent Director |
| Mr. Suresh Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Fundviser Capital (India) Ltd?
Fundviser Capital (India) Ltd's intrinsic value (as of 07 November 2025) is 281.50 which is 31.54% higher the current market price of 214.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 126 Cr. market cap, FY2025-2026 high/low of 281/112, reserves of ₹11.43 Cr, and liabilities of 16.81 Cr.
What is the Market Cap of Fundviser Capital (India) Ltd?
The Market Cap of Fundviser Capital (India) Ltd is 126 Cr..
What is the current Stock Price of Fundviser Capital (India) Ltd as on 07 November 2025?
The current stock price of Fundviser Capital (India) Ltd as on 07 November 2025 is 214.
What is the High / Low of Fundviser Capital (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fundviser Capital (India) Ltd stocks is 281/112.
What is the Stock P/E of Fundviser Capital (India) Ltd?
The Stock P/E of Fundviser Capital (India) Ltd is 372.
What is the Book Value of Fundviser Capital (India) Ltd?
The Book Value of Fundviser Capital (India) Ltd is 32.2.
What is the Dividend Yield of Fundviser Capital (India) Ltd?
The Dividend Yield of Fundviser Capital (India) Ltd is 0.00 %.
What is the ROCE of Fundviser Capital (India) Ltd?
The ROCE of Fundviser Capital (India) Ltd is 3.76 %.
What is the ROE of Fundviser Capital (India) Ltd?
The ROE of Fundviser Capital (India) Ltd is 2.88 %.
What is the Face Value of Fundviser Capital (India) Ltd?
The Face Value of Fundviser Capital (India) Ltd is 10.0.